WeRide Inc. heads into mid-June with the story running in reverse: the short covering and bullish options tilt that defined last week's note have both unwound sharply, leaving the stock down 16.5% on the week to $6.47.
The most consequential shift is in short positioning. Just one week ago this note described bears quietly retreating, with short interest at 3.2% of free float after an 11% weekly decline. That move has fully reversed. Short interest has climbed 15.4% over the past week to 3.7% of free float — roughly 12.6 million shares — with the largest single-day jump of the recent series arriving Tuesday. The ORTEX short score has climbed every session this week, reaching 58.7 on Tuesday from 55.8 at last Friday's close. Borrow availability has tightened meaningfully too, dropping to 49.5% from 55.7% a week ago — meaning barely one share is still available for every two already on loan. That is approaching the tight end of the past year's range, where availability touched a low of 24% in mid-May. Cost to borrow remains low at 0.82%, so while the lending pool is tightening, it has not yet repriced to reflect the squeeze on supply.
Options traders, meanwhile, are not hedging into the decline. The put/call ratio is essentially flat at 0.27, almost exactly at its 20-day average of 0.28 — a stark contrast to the call-heavy posture of the prior week. The z-score of -0.15 is statistically inert. With the 52-week PCR high at 0.65 and the low at 0.14, the current reading sits well toward the bullish end of the historical range, but the trend has stalled. Options participants are neither adding protection nor pressing upside bets — they are waiting.
The Street's view adds its own tension. Every analyst who covers WeRide carries a Buy rating — HSBC, BofA Securities, Citi, UBS, JPMorgan, and Morgan Stanley all initiated with positive calls between late 2024 and March 2026. The most recent initiation, HSBC in late March, set a target of $11.40. Even that most cautious formal target implies 76% upside from Tuesday's close. The mean target across the coverage group is materially higher, though several of the older targets — JPMorgan's $21 and Morgan Stanley's $23 — date back to early-to-mid 2025 and should be read in that context given how far the stock has fallen. The price-to-book multiple has compressed roughly 16% over the past week to 2.6x, consistent with the price decline. The EPS momentum factor score over 90 days ranks in the 96th percentile, suggesting the longer-dated earnings trajectory looks better than the near-term picture — a setup the previous note identified in late May and which has not materially changed.
Institutional ownership adds another layer worth noting. Uber Technologies disclosed holding nearly 18.75 million shares as of Q1 2026 — a new position — while Morgan Stanley's investment management arm added roughly 8.9 million shares in the same period. Those filings are Q1 data, pre-dating the current price decline. Whether those positions have been adjusted is unknown, but the presence of a large strategic holder like Uber alongside active institutional accumulation at higher prices frames the current weakness differently from a purely speculative name. The next earnings event is scheduled for August 12.
What to watch into August: whether the tightening borrow availability continues toward the mid-May lows, and whether the sustained short interest rebuild at falling prices prompts the cost to borrow to reprice — that combination would change the character of the short setup considerably.
See the live data behind this article on ORTEX.
Open WRD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
